Case Study: a biotechnology firm achieves scalable pharmacovigilance compliance with WNS automation

Pharmacovigilance cuts case-handling time and boosts accuracy with WNS

The customer, a prominent biotechnology firm, struggled with manual, labor-intensive pharmacovigilance processes across its vast product portfolio. This led to high error rates, hindered scalability and delays in adverse event reporting. WNS stepped in as a digital transformation partner to address these challenges.

WNS implemented a tailored Software-as-a-SaaS (SaaS) solution to automate the end-to-end handling of adverse events. This resulted in significant cost savings, a more than 50 percent reduction in case-handling time, and a system scaled to handle millions of cases daily with over 95 percent data accuracy. The WNS solution enabled holistic digital transformation of the client's pharmacovigilance operations.